News
Academy
Publications
All PublicationsE-Books
Media
Editorial PodcastsEditorial VideosPeer ExchangePractice AcademySponsored PodcastsSponsored Videos
More
Conferences
Conference CoverageConference Listing
Columns
All ColumnsA Closing ThoughtClinical Trial InsightsView from BrusselsView from Washington
Resources
AdvertiseBlogsEventsFront & CenterPartner PerspectivesWhite Papers
Webcasts

Subscribe

  • News
  • Academy
  • Publications
  • Media
  • Conferences
  • Columns
  • Resources
  • Webcasts
  • Subscribe
  • Clinical Operations & Strategy
    • Decentralized Clinical Trials
    • Trial Design
    • Investigative Sites
    • CRO/Sponsor
    • Risk-Based Monitoring
    • Protocol Design
    • Clinical Trial Supply Chain
    • Study Start-Up
    • Early Phase Development
  • DEI
    • Industry Initiatives
    • Diversity Action Plans
    • Recruitment
  • Data Management
    • Analytics
    • Electronic Data Capture
    • Real World Evidence
    • Metrics & Benchmarks
  • Patient Participation
    • Integrated Research
    • CRAACO
    • Enrollment
  • Regulatory
    • Institutional Review Board & Ethics Committee
    • FDA
    • EMA
  • Technology
    • Artificial Intelligence/Machine Learning
    • eClinical
    • mHealth
Spotlight -
Conference Coverage|
Peer Exchange|
DE&I|
Editorial Videos|
CNS Drug Development Resources
Advertisement
|Articles|November 11, 2015

RBM Toolkit: Top 10 Core Key Risk Indicators

Author(s)Duncan Hall
Advertisement

.

External Link - TRI KRI Starter Kit final.pdf

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!
Advertisement

Related Content

Advertisement
Image Credit: © Murrstock - stock.adobe.com

A Signal Isn’t Resolved Until It Stays Closed—RBQM Lessons

BySylviane de Viron,Melissa Thomas
January 19th 2026
© putilov_denis - © putilov_denis - stock.adobe.com

Securing Comparator Drugs in Competitive EU Markets: Challenges and Practical Solutions

BySyed Fazle Rob, RPh
January 7th 2026

The CRA Role’s Co-evolution With Clinical Trial Technology

ByHelen Yeardley
November 26th 2025
© Kaikoro - © Kaikoro - stock.adobe.com

Honing the Power of AI for Next Generation Trial Oversight and Execution

ByRichard Young
October 21st 2025

KRI Overload: When More Isn’t Better

BySylviane de Viron,Melissa Thomas,Frédéric Blais, PhD
October 14th 2025
Advertisement
Advertisement

Trending on Applied Clinical Trials Online

1

The Evolution of Global Trial Strategies in Today's Complex Healthcare Landscape

2

FDA RWE Guidance Redefines Data Use in Clinical Operations

3

ACT Brief: Global Trials Scale Up, Site-Centric Startup Gains Focus, and Pfizer Expands Vaccine Partnerships

4

Centering Site Experience to Accelerate Study Activation

5

ACT Brief: Life Sciences Hold the Line on DEI, Startup Timelines Stretch Further, and Regulators Align on AI Governance

  • About
  • Advertise
  • Contact Us
  • Editorial Contacts
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • Applied Clinical Trials
  • BioPharm International
  • Cannabis Science and Technology
  • Chromatography Online
  • Nutritional Outlook
  • Pharmaceutical Commerce
  • Pharmaceutical Executive
  • Pharm Tech
  • Spectroscopy Online
  • Turbo Machinery Magazine
IS1
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us